Janus Henderson Group’s Standard BioTools LAB Stock Holding History

Janus Henderson Group’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$121K	Hold	131,610	–	–	﹤0.01%	2386
2025 Q4	$168K	Hold	131,610	–	–	﹤0.01%	2367
2025 Q3	$172K	Hold	131,610	–	–	﹤0.01%	2363
2025 Q2	$157K	Hold	131,610	–	–	﹤0.01%	2363
2025 Q1	$149K	Hold	131,610	–	–	﹤0.01%	2419
2024 Q4	$230K	Hold	131,610	–	–	﹤0.01%	2368
2024 Q3	$253K	Hold	131,610	–	–	﹤0.01%	2345
2024 Q2	$232K	Buy	131,610 +59,549	+83%	+$146K	﹤0.01%	2336
2024 Q1	$196K	Buy	+72,061	New	+$174K	﹤0.01%	2427
2022 Q2	–	Sell	-14,408	Closed	-$52K	–	2641
2022 Q1	$52K	Buy	14,408 +1	+0%	+$3	﹤0.01%	2619
2021 Q4	$56K	Buy	+14,407	New	+$67.4K	﹤0.01%	2535

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Janus Henderson Group's LAB Position: Q1 2026 in Review

Janus Henderson Group held its Standard BioTools (LAB) position steady in Q1 2026 at 131,610 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2386.

Janus Henderson Group first reported a position in LAB in Q4 2021 and has held it in 11 quarters since. The position peaked at $253K in Q3 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Janus Henderson Group held 131,610 shares of Standard BioTools worth $121K as of Q1 2026.
Janus Henderson Group left its Standard BioTools share count unchanged in Q1 2026.
Standard BioTools made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2386 holding.
Janus Henderson Group first reported a position in Standard BioTools in Q4 2021 and has held it in 11 quarters since.
Janus Henderson Group's Standard BioTools position peaked at $253K in Q3 2024.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.